Klp Kapitalforvaltning As Kymera Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 7,700 shares of KYMR stock, worth $264,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,700Holding current value
$264,957% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
64.6MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$229 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$206 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$178 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$168 Million32.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$168 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.88B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...